Kenvue Declares Quarterly Dividend of $0.2075 per Share
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy KVUE?
Source: seekingalpha
- Quarterly Dividend Announcement: Kenvue has declared a quarterly dividend of $0.2075 per share, consistent with previous distributions, demonstrating the company's ongoing ability to maintain stable cash flows, which is likely to attract income-seeking investors.
- Dividend Yield: The forward yield of 4.73% reflects the company's attractiveness in the current market environment, potentially increasing investor interest in Kenvue's stock, especially in a low-interest-rate context.
- Shareholder Record Dates: The dividend will be payable on May 27, with a record date of May 13 and an ex-dividend date also on May 13, ensuring shareholders receive timely returns and further solidifying trust between the company and its investors.
- Market Reaction Expectations: Despite facing merger pressures and high valuation concerns, Kenvue's stable dividend policy may alleviate some market worries regarding its future performance, helping the company maintain its appeal in a competitive landscape.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KVUE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KVUE
Wall Street analysts forecast KVUE stock price to rise
8 Analyst Rating
1 Buy
7 Hold
0 Sell
Hold
Current: 17.530
Low
17.00
Averages
18.86
High
23.00
Current: 17.530
Low
17.00
Averages
18.86
High
23.00
About KVUE
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Quarterly Dividend Announcement: Kenvue has declared a quarterly dividend of $0.2075 per share, consistent with previous distributions, demonstrating the company's ongoing ability to maintain stable cash flows, which is likely to attract income-seeking investors.
- Dividend Yield: The forward yield of 4.73% reflects the company's attractiveness in the current market environment, potentially increasing investor interest in Kenvue's stock, especially in a low-interest-rate context.
- Shareholder Record Dates: The dividend will be payable on May 27, with a record date of May 13 and an ex-dividend date also on May 13, ensuring shareholders receive timely returns and further solidifying trust between the company and its investors.
- Market Reaction Expectations: Despite facing merger pressures and high valuation concerns, Kenvue's stable dividend policy may alleviate some market worries regarding its future performance, helping the company maintain its appeal in a competitive landscape.
See More
- Kimberly-Clark Stability: Kimberly-Clark (KMB) has maintained operating income between $2.3 billion and $2.8 billion over the past four years, with a current dividend yield of 5.3%; despite a drop in stock price due to acquisition risks related to Kenvue, its low valuation (forward P/E of just 13) makes it a solid long-term hold.
- T. Rowe Price Growth: T. Rowe Price Group (TROW) manages $1.7 trillion in assets, achieving $7.3 billion in revenue in 2025, a 13% increase over three years, and recently announced a 2.4% dividend increase, marking 40 consecutive years of shareholder payouts, reflecting its stable profitability and market demand.
- Realty Income Diversification: Realty Income (O), a REIT with clients across 92 industries, boasts a high occupancy rate of 99%, providing stability during economic fluctuations; it pays dividends monthly with a current yield of 5.1%, offering reliable cash flow for investors.
- FFO Growth Outlook: Realty Income's normalized funds from operations (FFO) reached nearly $3.9 billion last year, up 9% from the previous year, indicating a positive growth trend that suggests its dividends are likely to continue rising, enhancing its appeal as a quality dividend stock.
See More
- Kimberly-Clark Stability: Kimberly-Clark has maintained operating income between $2.3 billion and $2.8 billion over the past four years, with a current dividend yield of 5.3%; despite risks from the $48.7 billion Kenvue acquisition, its 92-year dividend history and 54 consecutive years of increases make it a solid investment choice.
- T. Rowe Price Growth Potential: As a leading investment management firm with $1.7 trillion in assets, T. Rowe Price achieved $7.3 billion in revenue in 2025, a 13% increase, and offers a 5.3% dividend yield, recently announcing a 2.4% increase marking 40 years of consecutive dividend growth, showcasing its strong profitability.
- Realty Income's Advantages: Realty Income operates across 92 industries with a high occupancy rate of 99%, making it a stable investment; last year, its normalized funds from operations (FFO) reached $3.9 billion, up 9%, and its monthly dividend payments attract investors seeking consistent cash flow.
- Attraction of Dividend Growth: Realty Income has announced 134 dividend increases since going public, with a current yield exceeding 5%, and its ongoing dividend growth and stable income stream highlight its long-term investment value, despite not being recommended by some analysts.
See More
- Earnings Announcement: Kenvue Inc. will release its Q1 2026 financial results before market open on May 7, 2026, demonstrating the company's commitment to transparency, despite not hosting a quarterly conference call to discuss the results.
- Transaction Impact: The decision to forgo a quarterly call due to the pending transaction with Kimberly-Clark may limit immediate investor feedback on the company's financial health, reflecting a cautious approach during significant transactions.
- Company Background: Kenvue Inc. is the world's largest pure-play consumer health company by revenue, boasting over a century of brand heritage with iconic names like Aveeno®, BAND-AID®, and Johnson's®, showcasing its strong influence in the global market.
- Brand Value: Kenvue emphasizes the extraordinary power of everyday care, highlighting its science-backed products and endorsements from healthcare professionals, aiming to enhance consumer loyalty and market share.
See More
- Dividend Investment Opportunity: As growth stocks rebound, investors can enter new dividend payers at relatively lower prices, particularly with PepsiCo's dividend yield rising to 3.7%, making it more attractive compared to Coca-Cola's 2.8%.
- PepsiCo Performance Recovery: Despite underperforming since 2023, PepsiCo's recent quarter saw a 2.6% organic revenue growth driven by innovation and price cuts, exceeding analysts' expectations and indicating potential for a rebound.
- Kenvue's Stable Returns: Kenvue, spun off from Johnson & Johnson, offers a 4.8% dividend yield despite slow revenue growth, appealing to investors seeking reliable cash flow, and is set to merge with Kimberly-Clark, enhancing its market position.
- Procter & Gamble's Consistent Growth: Procter & Gamble boasts a dividend yield of around 3% and has raised its annual per-share payout for 70 consecutive years, leveraging its strong brand and marketing capabilities to maintain a competitive edge in the consumer goods sector.
See More
- Dividend Increase: Procter & Gamble raised its quarterly dividend from $1.0568 to $1.0885 per share, resulting in an annual payout of $4.354 and a forward yield of 3%, reflecting the company's ongoing commitment to shareholder returns.
- Dividend King Status: This increase positions P&G among only five companies that have raised dividends for over 70 consecutive years, further solidifying its status as a Dividend King and attracting income-focused investors.
- Market Competitiveness: As the largest household and personal products company globally, P&G demonstrates resilience with an operating margin exceeding 20%, despite facing consumer spending challenges, showcasing its ability to maintain stability during economic fluctuations.
- Investment Opportunity: The recent stock sell-off has pushed P&G's dividend yield to a five-year high, with a price-to-earnings ratio of 21.4 and a forward P/E of 20.8, presenting an attractive buying opportunity for value investors looking to anchor their passive income portfolios.
See More









